OAM
CPRX

OP Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History

OP Asset Management’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,807
Closed -$365K – 816
2025
Q2 		$365K Hold
16,807
– – 0.01% 701
2025
Q1 		$408K Buy
+16,807
New +$378K 0.01% 705

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

OP Asset Management's CPRX Position: Q3 2025 in Review

OP Asset Management sold out of Catalyst Pharmaceutical (CPRX) in Q3 2025, closing a stake of 16,807 shares — an estimated $365K sold.

OP Asset Management first reported a position in CPRX in Q1 2025 and held it in 2 quarters. The position peaked at $408K in Q1 2025. 360 funds tracked by Wall St. Rank hold CPRX as of Q3 2025.

  • OP Asset Management reported no remaining Catalyst Pharmaceutical position as of Q3 2025 after selling out during the quarter.
  • OP Asset Management sold 16,807 Catalyst Pharmaceutical shares in Q3 2025, an estimated $365K.
  • OP Asset Management first reported a position in Catalyst Pharmaceutical in Q1 2025 and held it in 2 quarters.
  • OP Asset Management's Catalyst Pharmaceutical position peaked at $408K in Q1 2025.
  • 360 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2025.

Based on OP Asset Management's 13F filing for Q3 2025, filed 20 Apr 2026.